Biotech in focus: Is the sector poised for a comeback? – BNN Bloomberg

Skip to main content

ADVERTISEMENT

Money Talk

Biotech in focus: Is the sector poised for a comeback?

The biotech sector has been under pressure this year, but innovations in AI and breakthroughs in dealing with chronic diseases are helping to renew investor interest. Yaron Werber, Managing Director, Senior Biotechnology Analyst, TD Cowen, speaks with host Kim Parlee, Vice President, TD Wealth, to talk sector challenges and exciting developments in obesity, cardiology, endocrinology and more.

September 18, 2025 at 9:58AM EDT

Five things to know about FHSAsOpens in new window

06:46 · May 13, 2026 at 4:03PM EDT

Why higher oil prices aren't going awayOpens in new window

35:31 · May 07, 2026 at 11:33AM EDT

TDAM's new CIO on the market's resilience amid economic uncertaintyOpens in new window

15:01 · May 07, 2026 at 11:25AM EDT

Options spreads: What to know and how they workOpens in new window

07:09 · May 07, 2026 at 11:20AM EDT

Options trading: What to know and how to get startedOpens in new window

08:04 · May 04, 2026 at 10:25AM EDT

Have markets mispriced commodity risks as oil threat builds?Opens in new window

14:38 · April 30, 2026 at 10:55AM EDT

Why markets have been climbing despite wall of worryOpens in new window

14:08 · April 22, 2026 at 2:59PM EDT

Estate planning for UHNW families: Strategies to help avoid costly surprisesOpens in new window

13:17 · April 22, 2026 at 2:56PM EDT

How the oil shock is clouding the outlook for interest ratesOpens in new window

13:30 · April 16, 2026 at 4:36PM EDT

Succession planning: The different ways to exit your businessOpens in new window

07:04 · April 16, 2026 at 4:33PM EDT